These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 2496273

  • 1. Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine.
    Nicholls K, Mandel TE.
    Lab Invest; 1989 Apr; 60(4):486-91. PubMed ID: 2496273
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
    Gardiner TA, Anderson HR, Stitt AW.
    J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
    [Abstract] [Full Text] [Related]

  • 3. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y, Lin S, Zhou J.
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
    Agardh E, Hultberg B, Agardh C.
    Curr Eye Res; 2000 Jul; 21(1):543-9. PubMed ID: 11035534
    [Abstract] [Full Text] [Related]

  • 6. Long-term isografts of cultured fetal mouse pancreatic islets. The oncogenic effects of streptozotocin and the prevention of diabetic renal complications.
    Mandel TE, Hoffman L, Carter WM.
    Am J Pathol; 1981 Sep; 104(3):227-36. PubMed ID: 6457532
    [Abstract] [Full Text] [Related]

  • 7. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
    Chang KC, Tseng CD, Wu MS, Liang JT, Tsai MS, Cho YL, Tseng YZ.
    Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [Abstract] [Full Text] [Related]

  • 9. Collagen and bladder function in streptozotocin-diabetic rats: effects of insulin and aminoguanidine.
    Eika B, Levin RM, Longhurst PA.
    J Urol; 1992 Jul; 148(1):167-72. PubMed ID: 1535382
    [Abstract] [Full Text] [Related]

  • 10. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [Abstract] [Full Text] [Related]

  • 11. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA.
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
    Zuo Y, Gu Y, Ma J, Lin S.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 25; 82(4):239-43. PubMed ID: 11953170
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Promotion of wound collagen formation in normal and diabetic mice by quadrol.
    Bhide MV, Dunphy MJ, Mirkopulos N, Smith DJ.
    Immunopharmacol Immunotoxicol; 1988 Feb 25; 10(4):513-22. PubMed ID: 3246540
    [Abstract] [Full Text] [Related]

  • 17. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.
    Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G.
    Kidney Int; 1996 Aug 25; 50(2):627-34. PubMed ID: 8840295
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.